NEWS & MEDIA

New article in Cell Cycle that uses Cell2Sphere New article in Cell Cycle that uses our ready to us 3D cell culture solution, Cell2Sphere, as reference methodology to uncover novel therapeutic approaches.  Check it out!  
  New article in Carcinogenesis that uses Cell2Sphere New published article where our ready to use 3D cell culture solution, Cell2Sphere, is reference methodology to uncover novel approaches against cancer stem cells. Check it out!    
IPEM, the only international private equity and venture capital marketplace has selected StemTek to attend its 3rd event at Cannes from the 24th to the 26th of January. IPEM offers an innovative format with private spaces and lounges to conduct appointments and facilitate productive meetings, along a conferences and workshops program and networking events designed to engender the exchange of ideas, experiences and viewpoints.    
New article in Cell Cycle that uses Cell2Sphere New article in Cell Cycle that uses our ready to us 3D cell culture solution, Cell2Sphere, as reference methodology to uncover novel therapeutic approaches in triple negative breast cancer.  Check it out!  
Bridge to MassChallenge Biscay 2017 winners   Stemtek Therapeutic´s CEO, Angel Garcia Martin, had the pleasure to be invited to participate in the Bridge to MassChalenge Biscay 2017, a boot camp that took place from March 20th to the 23rd at the MassChallenge´s flagship office in Boston, Massachusetts.   During this 4-day boot camp, all 12 selected entrepreneurs from the Basque Country and the representatives from BEAZ had the chance to attend amazing speaker...
Back to top